OAC
KNSA icon

OMERS Administration Corp’s Kiniksa Pharmaceuticals KNSA Stock Holding History

OMERS Administration Corp’s Portfolio KNSA Stock Details KNSA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$631K Buy
+13,100
New +$580K ﹤0.01% 735
2025
Q4 		– Sell
-5,800
Closed -$225K – 1208
2025
Q3 		$225K Buy
+5,800
New +$188K ﹤0.01% 954

Other funds holding KNSA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

OMERS Administration Corp's KNSA Position: Q1 2026 in Review

OMERS Administration Corp opened a new position in Kiniksa Pharmaceuticals (KNSA) in Q1 2026: 13,100 shares worth $631K. The stake represents ﹤0.01% of the portfolio and ranks #735 among its holdings. This is a return to the name: OMERS Administration Corp previously reported a position in KNSA as recently as Q3 2025.

OMERS Administration Corp first reported a position in KNSA in Q3 2025 and has held it in 2 quarters since. 228 funds tracked by Wall St. Rank hold KNSA as of Q1 2026.

  • OMERS Administration Corp held 13,100 shares of Kiniksa Pharmaceuticals worth $631K as of Q1 2026.
  • Kiniksa Pharmaceuticals was a new OMERS Administration Corp position in Q1 2026.
  • Kiniksa Pharmaceuticals made up ﹤0.01% of OMERS Administration Corp's portfolio in Q1 2026, its #735 holding.
  • OMERS Administration Corp first reported a position in Kiniksa Pharmaceuticals in Q3 2025 and has held it in 2 quarters since.
  • 228 funds tracked by Wall St. Rank held Kiniksa Pharmaceuticals as of Q1 2026.

Based on OMERS Administration Corp's 13F filing for Q1 2026, filed 15 May 2026.